MarketCap
Facebook
X
TelegramGeschäftsbericht 2020
hinzugefügt 16.12.2023
Burford Capital Limited Kurshistorie 2011-2026 | BUR
Kurshistorie Jährlich Burford Capital Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.6 | 9.57 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.6 | 9.57 | 10.1 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.96 | -2.25 % | $ 500 M |  Britain |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K |  USA |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
133 | $ 11.68 | 21.41 % | $ 755 M | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 4.79 | 20.35 % | $ 10.4 B |  Israel |
 |
CASI Pharmaceuticals
CASI
|
8.4 | $ 0.83 | -2.51 % | $ 113 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 212.47 | 1.52 % | $ 5 B |  Danmark |
 |
Aclaris Therapeutics
ACRS
|
1.97 | $ 2.68 | 0.94 % | $ 207 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
63.4 | $ 37.22 | 4.17 % | $ 3.84 B | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M |  Canada |
 |
Catalyst Pharmaceuticals
CPRX
|
20.6 | $ 22.74 | 0.71 % | $ 2.69 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 100.27 | 2.22 % | $ 27.2 B | Germany |
 |
CorMedix
CRMD
|
3.42 | $ 11.22 | -0.36 % | $ 571 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
27 | $ 27.37 | -0.92 % | $ 1.33 B | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | $ 4.66 | - | $ 867 M | Germany |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.51 | $ 10.96 | -0.99 % | $ 722 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
BioVie
BIVI
|
1.65 | $ 1.37 | -1.26 % | $ 2.02 M | USA |
 |
Axon Enterprise
AXON
|
526 | $ 620.25 | -1.02 % | $ 47 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.84 | 4.41 % | $ 17.8 M | USA |
 |
AstraZeneca PLC
AZN
|
74.2 | $ 94.86 | -0.11 % | $ 96.9 B | Britain |
 |
Cellectis S.A.
CLLS
|
1.27 | $ 4.55 | 3.06 % | $ 116 M | France |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | USA |
 |
Biogen
BIIB
|
133 | $ 184.12 | 0.83 % | $ 26.8 B | USA |